文献速递眼底病与葡萄膜炎

糖尿病视网膜病变的代谢组学研究:系统综述

Metabolomics in Diabetic Retinopathy: A Systematic Review.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

本系统综述检索了PubMed和Web of Science截至2020年9月30日的人类代谢组学研究,纳入9项研究,发现l-谷氨酰胺、l-乳酸、丙酮酸、乙酸、l-谷氨酸、d-葡萄糖、l-丙氨酸、l-苏氨酸、瓜氨酸、l-赖氨酸和琥珀酸等反复被鉴定为糖尿病视网膜病变的潜在生物标志物,其中l-谷氨酰胺和瓜氨酸在所有生物样本中均发生变化,代谢通路涉及氨基酸和能量代谢的失调。

要点

  • l-谷氨酰胺和瓜氨酸在所有生物样本中均发生变化,是糖尿病视网膜病变的潜在生物标志物。
  • 反复鉴定的潜在生物标志物还包括l-乳酸、丙酮酸、乙酸、l-谷氨酸、d-葡萄糖等。
  • 代谢通路分析显示氨基酸和能量代谢失调参与糖尿病视网膜病变。

核心结论

  • 本综述总结了糖尿病视网膜病变的潜在代谢生物标志物和代谢通路,为这一糖尿病微血管并发症提供了新的致病通路见解。

研究设计与样本

  • 系统综述,检索PubMed和Web of Science截至2020年9月30日发表的人类代谢组学研究,最终纳入9项研究。

主要发现

  • 反复鉴定的潜在生物标志物包括l-谷氨酰胺、l-乳酸、丙酮酸、乙酸、l-谷氨酸、d-葡萄糖、l-丙氨酸、l-苏氨酸、瓜氨酸、l-赖氨酸和琥珀酸。
  • l-谷氨酰胺和瓜氨酸在所有生物样本中均发生变化。
  • 代谢通路失调涉及氨基酸代谢和能量代谢。

关键数值与推荐

  • 共纳入9项研究。
  • l-谷氨酰胺和瓜氨酸在所有生物样本中均发生变化。

临床怎么用

  • 上述潜在代谢生物标志物可能有助于糖尿病视网膜病变的风险分层,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Diabetic retinopathy (DR), a common microvascular complication of diabetes, is the leading cause of acquired blindness in the working-age population. Individuals with diabetes still develop DR despite appropriate glycemic and blood pressure control, highlighting the pressing need to identify useful biomarkers for risk stratification. The purpose of this review is to systematically summarize potential metabolic biomarkers and pathways of DR, which could facilitate developing an understanding of the disease mechanisms, as well as new therapeutic measures. METHODS: We searched PubMed and Web of Science for relevant metabolomics studies on humans published before September 30, 2020. Information regarding authors, title, publication date, study subjects, analytical platforms, methods of statistical analysis, biological samples, directions of change of potential metabolic biomarkers, and predictive values of metabolic biomarker panels was extracted, and the quality of the studies was assessed. Pathway analysis, including enrichment analysis and topology analysis, was derived from integrating differential metabolites using MetaboAnalyst 3.0, based on the Kyoto Encyclopedia of Genes and Genomes and Human Metabolome Database. RESULTS: We found nine studies focused on the identification of potential biomarkers. Repeatedly identified metabolites including l-glutamine, l-lactic acid, pyruvic acid, acetic acid, l-glutamic acid, d-glucose, l-alanine, l-threonine, citrulline, l-lysine, and succinic acid were found to be potential biomarkers of DR. It was observed that l-glutamine and citrulline changed in all biological samples. Dysregulation of metabolic pathways involved amino acid and energy metabolism. CONCLUSIONS: This review summarizes potential biomarkers and metabolic pathways, providing insights into new pathogenic pathways for this microvascular complication of diabetes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hou XW, Wang Y, Pan CW, et al. Metabolomics in Diabetic Retinopathy: A Systematic Review. Invest Ophthalmol Vis Sci. 2021. PMID: 34347011. doi:10.1167/iovs.62.10.4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。